Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. It blocks viral entry into host cells while preserving normal immunologic function. The Company is also investigating an intramuscular method of administration of Trogarzo. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy.


TSX:TH - Post by User

Post by Kd5513on Aug 15, 2023 7:18am
142 Views
Post# 35588446

Christmas times coming

Christmas times coming
Maybe for Christmas THERF will be able to re-start the trial, >2 weeks past said goal stated 4 weeks earlier....so in any other job the person who said this would be on a performance plan or would have been walked out the door for such a big miss, but its THERF so Paul only made 80K for those 2 weeks and counting......he laughs everytime he checks his bank account.

Have we met the delistment deadline (was it 2 weeks above $1) simple win there for a PR, but nope lets keep doing what we do which is nothing as the SP is doing wonders, they probably forgot they did a reverse split and still calculating it at 95 million shares. seriously wouldnt surprise me with them.
<< Previous
Bullboard Posts
Next >>